Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02071251 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery
A Phase 2 study of Wound Infection and Wound Complications, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT02071251 is a Phase 2 study of Wound Infection and Wound Complications that has completed, run by Washington University School of Medicine. The registered enrollment target is 105 participants, below the 368-participant average among 10 other Wound Infection trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02071251, a Phase 2 study of Wound Infection and Wound Complications, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately 500,000 surgical site infections occur annually in the US. These lead to worse patient quality of life, more outpatient and emergency room visits, readmissions and home services, with an estimated increase in costs of at least $3500 per complication. Surgical site infections are associated with increasing body mass index. There is limited and conflicting data of the utility of multiple surgical interventions to decrease the risk of surgical site complications. The investigators explored the effect of a prospective care pathway for closure of vertical abdominal wounds on patient's wound complications.
Conditions Studied
Interventions
- PROCEDURE Prospective wound complication protocol
Study Locations (1)
Missouri
- Washington University School of Medicine and Barnes Jewish Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02071251
The ClinicalTrials.gov registry entry for NCT02071251 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 368-participant average among 10 other Wound Infection trials with a reported enrollment target (71% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Wound Infection appearing as the primary indexed condition, and to 1 intervention - of which Prospective wound complication protocol is the first listed.
NCT02071251 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02071251 about?
NCT02071251 is a clinical study titled "A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery". Approximately 500,000 surgical site infections occur annually in the US. These lead to worse patient quality of life, more outpatient and emergency room visits, readmissions and home services, with an estimated increase in costs of at least $3500 per complication. Surgical site infections are associ...
What is the current status of trial NCT02071251?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2011-12. Estimated completion is 2013-07.
What conditions does trial NCT02071251 study?
This clinical trial studies the following conditions: Wound Infection, Wound Complications, Wound Separation.
What interventions are being tested in trial NCT02071251?
The interventions under investigation include: Prospective wound complication protocol (PROCEDURE).
Who is sponsoring clinical trial NCT02071251?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02071251 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tobramycin Injection to Prevent Infection in Open Fractures
ACTIVE NOT RECRUITING · Phase 3
-
Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation
COMPLETED · Phase 4
-
Activated Carbon Interphase Effect on Biofilm and Total Bacterial Load
COMPLETED · NA
-
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
COMPLETED · Phase 1
-
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
COMPLETED · Phase 3
-
Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.